Journal of pharmaceutical policy and practice

Keyphrases

Publications

volume 17, number 1, 2024

Maria Inês Teodoro, Alexandra Mayer, Ana da Costa Miranda, Hugo Nunes, Filipa Alves da Costa, António Lourenço
Real-world effectiveness of aromatase inhibitors and fulvestrant in HR+/HER2- advanced breast cancer: a snapshot of the last two years before conventional use of CDK 4/6 inhibitors in a Portuguese institution. Journal of pharmaceutical policy and practice 17 (1) (2024)
Ali Makki, Carolyn A Day, Betty Bouad Chaar
Professional stigma towards clients with methamphetamine use disorder - a qualitative study. Journal of pharmaceutical policy and practice 17 (1) (2024)
Jiayue Chen, Haisu Feng, Jiatong Sun, Yawen Jiang
Omicron wave during December 2022 - January 2023: access to pharmaceuticals and healthcare resources and impacts on health outcomes in Shenzhen, China. Journal of pharmaceutical policy and practice 17 (1) (2024)
Anna David, Omary Swalehe, Jean D' Amour Habagusenga, Stany Banzimana, Domina Asingizwe, Frank Chacky, Fabrizio Molteni
Accessibility of malaria commodities in Geita District Council, mainland Tanzania: the experiences from healthcare providers and clients. Journal of pharmaceutical policy and practice 17 (1) (2024)
Falisy Lule, Kalid Rajab, Stany Banzimana, Domina Asingizwe
Assessing determinants of the availability of HIV tracer commodities in health facilities in Wakiso District, Uganda. Journal of pharmaceutical policy and practice 17 (1) (2024)
Doris Mollel, Godeliver A Kagashe, Domina Asingizwe, Stany Banzimana, Shital M Maru, François Niragire
Barriers to access of maternal health commodities among pregnant women in public health facilities in Ubungo Municipal Council, Tanzania. Journal of pharmaceutical policy and practice 17 (1) (2024)
Omar Qureshi, Reshma Ramachandran, Joseph R Ross
Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016-2019 data. Journal of pharmaceutical policy and practice 17 (1) (2024)
Philip Howard, Gillian Hawksworth, Sara Hussain, Nafeesa Khan, Rabiya Bahadar, Jill Msindo, Sarah Frank, Mamoon A Aldeyab
Exploring barriers and enablers of antibiotic amnesty campaigns. Journal of pharmaceutical policy and practice 17 (1) (2024)
Omar Qureshi, Reshma Ramachandran, Joseph R Ross
Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016-2019 data. Journal of pharmaceutical policy and practice 17 (1) (2024)
Omar Qureshi, Reshma Ramachandran, Joseph R Ross
Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016-2019 data. Journal of pharmaceutical policy and practice 17 (1) (2024)
Anna David, Omary Swalehe, Jean D' Amour Habagusenga, Stany Banzimana, Domina Asingizwe, Frank Chacky, Fabrizio Molteni
Accessibility of malaria commodities in Geita District Council, mainland Tanzania: the experiences from healthcare providers and clients. Journal of pharmaceutical policy and practice 17 (1) (2024)
Kheloud Awad, Myriam Jaam, Ahmed Awaisu, Derek Stewart, Hassaan Anwer Rathore, Muhammad Abdul Hadi
Impact of pharmaceutical care interventions in improving clinical outcomes among patients with pulmonary tuberculosis: a systematic review. Journal of pharmaceutical policy and practice 17 (1) (2024)
Maria Inês Teodoro, Alexandra Mayer, Ana da Costa Miranda, Hugo Nunes, Filipa Alves da Costa, António Lourenço
Real-world effectiveness of aromatase inhibitors and fulvestrant in HR+/HER2- advanced breast cancer: a snapshot of the last two years before conventional use of CDK 4/6 inhibitors in a Portuguese institution. Journal of pharmaceutical policy and practice 17 (1) (2024)
Jiayue Chen, Haisu Feng, Jiatong Sun, Yawen Jiang
Omicron wave during December 2022 - January 2023: access to pharmaceuticals and healthcare resources and impacts on health outcomes in Shenzhen, China. Journal of pharmaceutical policy and practice 17 (1) (2024)
Ola Yakti, Daoud Al-Badriyeh, Mohammed Rijims, Mohammed Abdelaal, Omar Alsoukhni, Moza Al Hail, Palli Valapila Abdulrouf, Wessam El-Kassem, Fouad Abounahia, Rasha Kaddoura, Dina Abushanab
Clinical pharmacists' interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis. Journal of pharmaceutical policy and practice 17 (1) (2024)
Agaba Robert, Ndinawe Johnmark, Kabera Makuza Radiana, Kiiza Haulat, Segawa Ivan, Kalidi Rajab, Keren Ebong
Evaluating the role of intern pharmacists in pharmaceutical care in hospitals in Uganda. Journal of pharmaceutical policy and practice 17 (1) (2024)
Ammar Abdulrahman Jairoun, Faris El-Dahiyat, Ghaleb A ElRefae, Sabaa Saleh Al-Hemyari, Moyad Shahwan, Samer H Zyoud, Khawla Abu Hammour, Zaheer Ud-Din Babaar
Detecting manuscripts written by generative AI and AI-assisted technologies in the field of pharmacy practice. Journal of pharmaceutical policy and practice 17 (1) (2024)
Parun Rutjanathamrong, Tuangrat Phodha, Thanawat Wongphan, Sirikorn Sujinnaprum, Noppakun Thammatacharee
Value of pharmacy services for common illness symptoms covered by universal coverage at drugstore compared to outpatient services at a hospital in Thailand. Journal of pharmaceutical policy and practice 17 (1) (2024)
Iris R Joosse, Hendrika A van den Ham, Aukje K Mantel-Teeuwisse, Fatima Suleman
The caregiver's experience of childhood cancer treatment in South Africa. Journal of pharmaceutical policy and practice 17 (1) (2024)
Mari Iwata, Mika Maezawa, Koumi Miyasaka, Sakiko Hirofuji, Takaaki Suzuki, Satoshi Nakao, Hirofumi Tamaki, Nanaka Ichihara, Yuka Nokura, Mayuko Masuta, Hiroaki Uranishi, Yuri Nishibata, Kazuhiro Iguchi, Mitsuhiro Nakamura
Survey of community and hospital pharmacist involvement in outpatient chemotherapy using Japanese health information data. Journal of pharmaceutical policy and practice 17 (1) (2024)
Philip Howard, Gillian Hawksworth, Sara Hussain, Nafeesa Khan, Rabiya Bahadar, Jill Msindo, Sarah Frank, Mamoon A Aldeyab
Exploring barriers and enablers of antibiotic amnesty campaigns. Journal of pharmaceutical policy and practice 17 (1) (2024)
Audace Manirakiza, David Gitonga Nyamu, Shital Mahindra Maru, Thomas Bizimana, Manassé Nimpagaritse
Evaluating drug use patterns among paediatric outpatients in Burundi. Journal of pharmaceutical policy and practice 17 (1) (2024)
Mahmathi Karuppannan, Long Chiau Ming, Mohd Shahezwan Abd Wahab, Zakiah Mohd Noordin, Shermaine Yee, Ayu Wulan Dwiputri
Self-reported side effects of COVID-19 vaccines among the public. Journal of pharmaceutical policy and practice 17 (1) (2024)
Mahmathi Karuppannan, Long Chiau Ming, Mohd Shahezwan Abd Wahab, Zakiah Mohd Noordin, Shermaine Yee, Ayu Wulan Dwiputri
Self-reported side effects of COVID-19 vaccines among the public. Journal of pharmaceutical policy and practice 17 (1) (2024)
Natanim Degefu, Abera Jambo, Lemma Demissie Regassa, Melaku Getachew
In-hospital outcome and its predictors among patients with acute cardiogenic pulmonary oedema at a tertiary hospital in Harar, Eastern Ethiopia: a retrospective cohort study. Journal of pharmaceutical policy and practice 17 (1) (2024)
Falisy Lule, Kalid Rajab, Stany Banzimana, Domina Asingizwe
Assessing determinants of the availability of HIV tracer commodities in health facilities in Wakiso District, Uganda. Journal of pharmaceutical policy and practice 17 (1) (2024)
Thanompong Sathienluckana, Sirinoot Palapinyo, Kitiyot Yotsombut, Ekgaluck Wanothayaroj, Pasiri Sithinamsuwan, Naeti Suksomboon
Expert consensus guidelines for community pharmacists in the management of diabetic peripheral neuropathy with a combination of neurotropic B vitamins. Journal of pharmaceutical policy and practice 17 (1) (2024)
Thanompong Sathienluckana, Sirinoot Palapinyo, Kitiyot Yotsombut, Ekgaluck Wanothayaroj, Pasiri Sithinamsuwan, Naeti Suksomboon
Expert consensus guidelines for community pharmacists in the management of diabetic peripheral neuropathy with a combination of neurotropic B vitamins. Journal of pharmaceutical policy and practice 17 (1) (2024)
Kheloud Awad, Myriam Jaam, Ahmed Awaisu, Derek Stewart, Hassaan Anwer Rathore, Muhammad Abdul Hadi
Impact of pharmaceutical care interventions in improving clinical outcomes among patients with pulmonary tuberculosis: a systematic review. Journal of pharmaceutical policy and practice 17 (1) (2024)
Bayan Faisal Ababneh, Siew Chin Ong, Iffat Elbarazi, Hisham Zaidon Aljamal, Rabia Hussain
A qualitative study exploring community pharmacists' awareness, attitudes and perceptions about drive-thru community pharmacy service in Malaysia during COVID-19. Journal of pharmaceutical policy and practice 17 (1) (2024)
Bayan Faisal Ababneh, Siew Chin Ong, Iffat Elbarazi, Hisham Zaidon Aljamal, Rabia Hussain
A qualitative study exploring community pharmacists' awareness, attitudes and perceptions about drive-thru community pharmacy service in Malaysia during COVID-19. Journal of pharmaceutical policy and practice 17 (1) (2024)
Ola Yakti, Daoud Al-Badriyeh, Mohammed Rijims, Mohammed Abdelaal, Omar Alsoukhni, Moza Al Hail, Palli Valapila Abdulrouf, Wessam El-Kassem, Fouad Abounahia, Rasha Kaddoura, Dina Abushanab
Clinical pharmacists' interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis. Journal of pharmaceutical policy and practice 17 (1) (2024)
Mahmoud Youness, Sara Mansour, Fouad Sakr, Samer Olabi, Sarah Atwi, Iman Younes Martinez, Sami El Khatib, Souheil Hallit, Pascale Salameh, Diana Malaeb, Hassan Hosseini
Odds and associated factors for thrombosis development among Lebanese COVID-19 patients: a case-control retrospective study. Journal of pharmaceutical policy and practice 17 (1) (2024)
Doris Mollel, Godeliver A Kagashe, Domina Asingizwe, Stany Banzimana, Shital M Maru, François Niragire
Barriers to access of maternal health commodities among pregnant women in public health facilities in Ubungo Municipal Council, Tanzania. Journal of pharmaceutical policy and practice 17 (1) (2024)
Eman Nawash Alhmoud, Safa Farooq Fouad Alrawi, Rasha El Enany, Mohamed Izham Mohamed Ibrahim, Muhammad Abdul Hadi
Impact of pharmacist-supported transition of care services in the Middle East and North Africa: a systematic review and meta-analysis. Journal of pharmaceutical policy and practice 17 (1) (2024)
Eman Nawash Alhmoud, Safa Farooq Fouad Alrawi, Rasha El Enany, Mohamed Izham Mohamed Ibrahim, Muhammad Abdul Hadi
Impact of pharmacist-supported transition of care services in the Middle East and North Africa: a systematic review and meta-analysis. Journal of pharmaceutical policy and practice 17 (1) (2024)
Agaba Robert, Ndinawe Johnmark, Kabera Makuza Radiana, Kiiza Haulat, Segawa Ivan, Kalidi Rajab, Keren Ebong
Evaluating the role of intern pharmacists in pharmaceutical care in hospitals in Uganda. Journal of pharmaceutical policy and practice 17 (1) (2024)
Ammar Abdulrahman Jairoun, Faris El-Dahiyat, Ghaleb A ElRefae, Sabaa Saleh Al-Hemyari, Moyad Shahwan, Samer H Zyoud, Khawla Abu Hammour, Zaheer Ud-Din Babaar
Detecting manuscripts written by generative AI and AI-assisted technologies in the field of pharmacy practice. Journal of pharmaceutical policy and practice 17 (1) (2024)
Ali Makki, Carolyn A Day, Betty Bouad Chaar
Professional stigma towards clients with methamphetamine use disorder - a qualitative study. Journal of pharmaceutical policy and practice 17 (1) (2024)
Muhammad Akhtar Abbas Khan, Asim Rauf
Promoting local production and active pharmaceutical ingredient (API) industry in low and middle income countries (LMICs): impact on medicines access and policy. Journal of pharmaceutical policy and practice 17 (1) (2024)
Parun Rutjanathamrong, Tuangrat Phodha, Thanawat Wongphan, Sirikorn Sujinnaprum, Noppakun Thammatacharee
Value of pharmacy services for common illness symptoms covered by universal coverage at drugstore compared to outpatient services at a hospital in Thailand. Journal of pharmaceutical policy and practice 17 (1) (2024)
Muhammad Akhtar Abbas Khan, Asim Rauf
Promoting local production and active pharmaceutical ingredient (API) industry in low and middle income countries (LMICs): impact on medicines access and policy. Journal of pharmaceutical policy and practice 17 (1) (2024)
Audace Manirakiza, David Gitonga Nyamu, Shital Mahindra Maru, Thomas Bizimana, Manassé Nimpagaritse
Evaluating drug use patterns among paediatric outpatients in Burundi. Journal of pharmaceutical policy and practice 17 (1) (2024)
Gerald Manzi Mbabazize, Vedaste Kagisha, Kato J Njunwa, Joseph Oloro
The effect of prescription patterns on the performance of the pharmacy department of a Regional Referral Hospital, Uganda. Journal of pharmaceutical policy and practice 17 (1) (2024)
Shahd Al-Arkee, Julie Mason, M Sayeed Haque, Abdullah A Alshehri, Zahraa Jalal
Pharmacist management of atrial fibrillation in UK primary care: a cross-sectional study. Journal of pharmaceutical policy and practice 17 (1) (2024)
Mahmoud Youness, Sara Mansour, Fouad Sakr, Samer Olabi, Sarah Atwi, Iman Younes Martinez, Sami El Khatib, Souheil Hallit, Pascale Salameh, Diana Malaeb, Hassan Hosseini
Odds and associated factors for thrombosis development among Lebanese COVID-19 patients: a case-control retrospective study. Journal of pharmaceutical policy and practice 17 (1) (2024)
Mari Iwata, Mika Maezawa, Koumi Miyasaka, Sakiko Hirofuji, Takaaki Suzuki, Satoshi Nakao, Hirofumi Tamaki, Nanaka Ichihara, Yuka Nokura, Mayuko Masuta, Hiroaki Uranishi, Yuri Nishibata, Kazuhiro Iguchi, Mitsuhiro Nakamura
Survey of community and hospital pharmacist involvement in outpatient chemotherapy using Japanese health information data. Journal of pharmaceutical policy and practice 17 (1) (2024)
Iris R Joosse, Hendrika A van den Ham, Aukje K Mantel-Teeuwisse, Fatima Suleman
The caregiver's experience of childhood cancer treatment in South Africa. Journal of pharmaceutical policy and practice 17 (1) (2024)

volume 17, number Suppl 1, 2024